Abstract:Background DNA methylation occurs in the context of a CpG dinucleotide. It is an important epigenetic modification, which can be inherited through cell division. The two major types of methylation include hypomethylation and hypermethylation. Unique methylation patterns have been shown to exist in diseases including various types of cancer. DNA methylation analysis promises to become a powerful tool in cancer diagnosis, treatment and prognostication. Large-scale methylation arrays are now available for studying methylation genome-wide. The Illumina methylation platform simultaneously measures cytosine methylation at more than 1500 CpG sites associated with over 800 cancer-related genes. Cluster analysis is often used to identify DNA methylation subgroups for prognosis and diagnosis. However, due to the unique non-Gaussian characteristics, traditional clustering methods may not be appropriate for DNA and methylation data, and the determination of optimal cluster number is still problematic. Method A Dirichlet process beta mixture model (DPBMM) is proposed that models the DNA methylation expressions as an infinite number of beta mixture distribution. The model allows automatic learning of the relevant parameters such as the cluster mixing proportion, the parameters of beta distribution for each cluster, and especially the number of potential clusters. Since the model is high dimensional and analytically intractable, we proposed a Gibbs sampling "no-gaps" solution for computing the posterior distributions, hence the estimates of the parameters. Result The proposed algorithm was tested on simulated data as well as methylation data from 55 Glioblastoma multiform (GBM) brain tissue samples. To reduce the computational burden due to the high data dimensionality, a dimension reduction method is adopted. The two GBM clusters yielded by DPBMM are based on data of different number of loci (P-value < 0.1), while hierarchical clustering cannot yield statistically significant clusters.

A Bayesian Model for Identifying Cancer Subtypes from Paired Methylation Profiles

Identifying Methylation Pattern And Genes Associated With Breast Cancer Subtypes

Identifying Differential Methylation in Cancer Epigenetics via a Bayesian Functional Regression Model

Diagnostic classification based on DNA methylation profiles using sequential machine learning approaches.

A Nonparametric Bayesian Approach for Clustering Bisulfate-Based DNA Methylation Profiles

Specific Breast Cancer Prognosis-Subtype Distinctions Based on DNA Methylation Patterns.

A new parsimonious method for classifying Cancer Tissue-of-Origin Based on DNA Methylation 450K data

DNA methylation signatures for breast cancer classification and prognosis

DNA Methylation Markers for Diagnosis and Prognosis of Common Cancers.

Parenclitic Network Analysis of Methylation Data for Cancer Identification

DNA Methylation Based Molecular Subtypes Predict Prognosis in Breast Cancer Patients

Screening Dys-Methylation Genes and Rules for Cancer Diagnosis by Using the Pan-Cancer Study

Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis

Discovering DNA Methylation Patterns for Long Non-Coding RNAs Associated with Cancer Subtypes

The Identification of Specific Methylation Patterns across Different Cancers

A Bayesian framework to study tumor subclone-specific expression by combining bulk DNA and single-cell RNA sequencing data

Molecular Subtyping of Cancer Based on Distinguishing Co-Expression Modules and Machine Learning

A Hybrid Ensemble Approach for Identifying Robust Differentially Methylated Loci in Pan-Cancers

DNA methylation profiles capturing breast cancer heterogeneity

Differential Methylation Relative to Breast Cancer Subtype and Matched Normal Tissue Reveals Distinct Patterns

Integrative Model-based clustering of microarray methylation and expression data